Search

everythinglearnresearchcommunity

for

Search:↓

Wound healing is complex and requires more research to enhance treatment methods.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Minoxidil 5% works better than 2% for hair growth in male-patterned hair loss.

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Blocking JAK-STAT signaling can lead to hair growth.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Fluconazole can cause hair loss, but the exact cause is unknown.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

As people get older, they have less active hair growth, but women have thicker hair than men and respond better to hair loss treatments.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Laser device increases hair density, safe for treating hair loss in men and women.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.